Cardiac Amyloidosis Associated with Apolipoprotein A-IV Deposition Diagnosed by Mass Spectrometry-Based Proteomic Analysis
Authors:
- 27 November 2019
- journal article
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 6 (Vol 6 Iss ) , 001237
Abstract
Amyloidosis is a group of disorders characterised by the accumulation of extracellular deposits of insoluble protein aggregates. Clinical management depends on the accurate identification of the amyloid precursor and underlying cause. We describe a rare case of apolipoprotein A-IV cardiac amyloidosis, the diagnosis of which required mass spectrometry-based proteomic analysis.Keywords
This publication has 10 references indexed in Scilit:
- Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committeeAmyloid, 2018
- Apolipoprotein A-IV–Associated Cardiac AmyloidosisJACC, 2017
- Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosisKidney International, 2016
- Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCirculation, 2016
- Apolipoprotein A-IV: a protein intimately involved in metabolismJournal of Lipid Research, 2015
- Etiology of Amyloidosis Determines Myocardial 99mTc-DPD Uptake in Amyloidotic CardiomyopathyClinical Nuclear Medicine, 2015
- Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomicsHaematologica, 2014
- High99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathyAmyloid, 2012
- Amyloidosis-where are we now and where are we heading?Archives of Pathology & Laboratory Medicine, 2010
- Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrationsAtherosclerosis, 2000